Adamson P, Bray F, Costantini AS, Tao MH, Weiderpass E, Roman E. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer. 2007;43:391–401.
Article
PubMed
Google Scholar
Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204–10.
Article
PubMed
Google Scholar
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting–Airlie House, Virginia, November 1997. Hematol J. 2000;1:53–66.
Article
CAS
PubMed
Google Scholar
Tan DE, Foo JN, Bei JX, Chang J, Peng R, Zheng X, et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet. 2013;45:804–7.
Article
CAS
PubMed
Google Scholar
Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405–8.
Article
CAS
PubMed
Google Scholar
Chiu BC, Weisenburger DD, Zahm SH, Cantor KP, Gapstur SM, Holmes F, et al. Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2004;13:525–31.
CAS
PubMed
Google Scholar
Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, et al. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol. 2008;140:287–94.
Article
CAS
PubMed
Google Scholar
Shen M, Zheng T, Lan Q, Zhang Y, Zahm SH, Wang SS, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet. 2006;119:659–68.
Article
CAS
PubMed
Google Scholar
Chen S, Zhu JH, Wang F, Huang SY, Xue WQ, Cui Z, et al. Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin’s lymphoma: evidence from a meta-analysis. Chin J Cancer. 2015;34:108–14.
PubMed
Google Scholar
Wang YM, Guo W, Zhang XF, Li Y, Wang N, Ge H, et al. Correlations between serine hydroxymethyltransferase1 C1420T polymorphisms and susceptibilities to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Ai Zheng. 2006;25:281–6.
CAS
PubMed
Google Scholar
Schirch L, Peterson D. Purification and properties of mitochondrial serine hydroxymethyltransferase. J Biol Chem. 1980;255:7801–6.
CAS
PubMed
Google Scholar
Girgis S, Suh JR, Jolivet J, Stover PJ. 5-Formyltetrahydrofolate regulates homocysteine remethylation in human neuroblastoma. J Biol Chem. 1997;272:4729–34.
Article
CAS
PubMed
Google Scholar
Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000;130:129–32.
CAS
PubMed
Google Scholar
Zijno A, Andreoli C, Leopardi P, Marcon F, Rossi S, Caiola S, et al. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis. 2003;24:1097–103.
Article
CAS
PubMed
Google Scholar
Wang YM, Guo W, Zhang XF, Li Y, Wang N, Ge H, et al. Correlations between serine hydroxymethyltransferase1 C1420T polymorphisms and susceptibilities to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Ai Zheng. 2006;25:281–6 (in Chines).
CAS
PubMed
Google Scholar
Guerreiro CS, Carmona B, Goncalves S, Carolino E, Fidalgo P, Brito M, et al. Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients. Am J Clin Nutr. 2008;88:1413–8.
CAS
PubMed
Google Scholar
Heil SG, Van der Put NM, Waas ET, den Heijer M, Trijbels FJ, Blom HJ. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab. 2001;73:164–72.
Article
CAS
PubMed
Google Scholar
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Article
CAS
PubMed
Google Scholar
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
CAS
PubMed
Google Scholar
Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica. 2003;88:159–66.
CAS
PubMed
Google Scholar
Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood. 2004;104:2155–62.
Article
CAS
PubMed
Google Scholar
Lightfoot TJ, Skibola CF, Willett EV, Skibola DR, Allan JM, Coppede F, et al. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev. 2005;14:2999–3003.
Article
CAS
PubMed
Google Scholar
Lee KM, Lan Q, Kricker A, Purdue MP, Grulich AE, Vajdic CM, et al. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet. 2007;122:525–33.
Article
CAS
PubMed
Google Scholar
Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood. 2007;109:3050–9.
PubMed Central
CAS
PubMed
Google Scholar
Berglund M, Enblad G, Turesson I, Edman V, Thunberg U. Folate-metabolizing genes in lymphoma patients from Sweden. Scand J Immunol. 2009;70:408–10.
Article
CAS
PubMed
Google Scholar
Weiner AS, Beresina OV, Voronina EN, Voropaeva EN, Boyarskih UA, Pospelova TI, et al. Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin’s lymphoma. Leuk Res. 2011;35:508–15.
Article
CAS
PubMed
Google Scholar
Li Q, Lan Q, Zhang Y, Bassig BA, Holford TR, Leaderer B, et al. Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma. Cancer Causes Control. 2013;24:1875–84.
Article
PubMed Central
PubMed
Google Scholar
Niclot S, Pruvot Q, Besson C, Savoy D, Macintyre E, Salles G, et al. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood. 2006;108:278–85.
Article
CAS
PubMed
Google Scholar
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–42.
Article
PubMed
Google Scholar
Lucock M. Is folic acid the ultimate functional food component for disease prevention? BMJ. 2004;328:211–4.
Article
PubMed Central
CAS
PubMed
Google Scholar
Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G. Impact of folate deficiency on DNA stability. J Nutr. 2002;132:2444S–9S.
CAS
PubMed
Google Scholar
Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica. 2003;88:159–66.
CAS
PubMed
Google Scholar
Zhao TT, Shen LL, Zhang XL, Gu DY, Zhang Q, Huo XY, et al. Clinical significance of SHMT1 rs1979277 polymorphism in Asian solid tumors: evidence from a meta-analysis. Genet Mol Res. 2015;14:5602–14.
Article
CAS
PubMed
Google Scholar